C/O- Mr NK Mishra, N-1/256, Nayapalli, IRC Village, 751015 Bhubaneswar, Odisha, India.
Regional Medical research Centre, Chandrasekharpur, 751023 Bhubaneswar, Odisha, India.
Transfus Clin Biol. 2021 May;28(2):175-179. doi: 10.1016/j.tracli.2021.02.003. Epub 2021 Mar 4.
COVID 19 is an acute respiratory disease caused by infection by the virus SARS-COV-2 and has been declared as a pandemic whose specific treatment is still not established. One of the options in the treatment is Convalescent plasma (CP) therapy when there is presence of required amount of neutralizing antibodies in the plasma of recovered COVID patients. Our objective was to analyze the challenges and the constraints encountered in motivation of COVID 19 recovered persons to come for the screening procedures and to convince the selected persons to come for Plasma donation voluntarily.
MATERIAL & METHODS: The present retrospective observational study was conducted for a period of five and half months. Out of 1515 number of persons contacted telephonically for Plasma donation, 1291 persons came for screening of whom 1028 persons were eligible for donation, 263 cases were deferred and 966 persons finally donated.
Maximum number of acceptance cases were from males-(98.7%). Of the accepted cases, (41.73%) were from the 18-30 years' age group. 33.94% were from blood group 'O' Rh D positive giving maximum contribution from any blood group. 38.3% of the accepted cases had resolution of all COVID symptoms within time period of 28-40 days. Maximum number of accepted individuals (39.75%) had suffered from multiple symptoms followed by 39.02% of asymptomatic persons. Highest number of Plasma donation was contributed by Odisha Government Police personnel (51.56%).
In this global ongoing pandemic, the "Fear Factor of contracting the disease" has acted as a major challenge in motivating and convincing a COVID recovered patient for plasma donation. The challenge before the medical professionals was to motivate, educate and convince the potential donors and the society about the likely benefits of convalescent plasma. This could be finally overcome with the help of positive orientation through social and conventional media as well as mass appeal from government side on the benefits of plasma therapy in saving lives in the present pandemic.
COVID-19 是一种由病毒 SARS-CoV-2 感染引起的急性呼吸道疾病,已被宣布为大流行,但其具体治疗方法仍未确定。在治疗中,当康复的 COVID 患者的血浆中存在所需量的中和抗体时,一种选择是使用恢复期血浆(CP)疗法。我们的目的是分析在激励 COVID 康复者进行筛查程序以及说服选定的人自愿前来进行血浆捐献方面所面临的挑战和限制。
本回顾性观察研究进行了五个半月。在通过电话联系进行血浆捐献的 1515 人中,有 1291 人前来接受筛查,其中 1028 人符合捐献条件,263 人被推迟,966 人最终捐献。
接受人数最多的是男性-(98.7%)。在接受的病例中,(41.73%)来自 18-30 岁年龄组。来自 O 型血 Rh D 阳性的人数最多,占任何血型的最大比例。38.3%的接受者在 28-40 天的时间内所有 COVID 症状都得到了缓解。最多的接受者(39.75%)有多种症状,其次是 39.02%的无症状者。最多的血浆捐献者来自奥里萨邦政府警察人员(51.56%)。
在这场全球持续的大流行中,“感染疾病的恐惧因素”在激励和说服 COVID 康复患者进行血浆捐献方面构成了重大挑战。医务人员面临的挑战是,对潜在捐赠者和社会进行宣传、教育和说服,让他们了解恢复期血浆的可能益处。这最终可以通过社会和传统媒体的积极宣传以及政府方面对在当前大流行中使用血浆疗法拯救生命的好处的大力呼吁来克服。